Skip to main content
. 2017 Feb 21;1(4):237–246. doi: 10.1210/js.2016-1097

Table 1.

Baseline Characteristics of Study Participants

Mifepristone (n = 833) Placebo (n = 627)
Age (y) 44.7 ± 11.6 44.7 ± 11.2
Gender (% female) 57.9 60.5
ACTH (pg/mL) n = 778 n = 572
19.6 ± 12.5 22.5 ± 15.1
Serum cortisol (µg/dL) n = 807 n = 601
12.1 ± 5.4 12.4 ± 5.4
BMI (kg/m2) n = 534 n = 370
28.8 ± 5.2 28.7 ± 5.8
Systolic BP (mm Hg) 122.6 ± 12.9 123.4 ± 13.9
Diastolic BP (mm Hg) 78.2 ± 8.7 78.7 ± 9.4
Potassium (mEq/L) n = 776 n = 603
4.2 ± 0.4 4.3 ± 0.4
Sodium (mEq/L) n = 777 n = 607
140.4 ± 2.9 140.7 ± 2.8

Data are mean ± standard deviation unless stated otherwise. To convert the values for ACTH to picomoles per liter, multiply by 0.22. To convert the values for serum cortisol to nanomoles per liter, multiply by 27.6.

Abbreviations: BMI, body mass index; BP, blood pressure.